Target intelligence / Profile preview

Y-family DNA polymerase (Y-family Pols)

Target
Y-family Pols
Molecular classification
Enzyme, DNA-directed DNA polymerase, Transferase
01

Overview

Y-family DNA polymerases are a specialized group of enzymes, including Pol eta, Pol iota, Pol kappa, and Rev1, that facilitate translesion synthesis (TLS), a critical DNA damage tolerance mechanism (Yang, 2014). Unlike high-fidelity replicative polymerases, Y-family members possess a spacious and flexible active site that allows them to bypass bulky DNA lesions, such as UV-induced thymine dimers or platinum-based chemotherapy adducts, which would otherwise stall replication forks (Sale, 2013). While this process ensures cell survival by allowing replication to complete, it is inherently error-prone and is a primary driver of both spontaneous and damage-induced mutagenesis (Ghosal & Chen, 2013). In oncology, the overexpression of these polymerases is a major factor in chemoresistance, as they enable cancer cells to tolerate and recover from DNA-damaging treatments like cisplatin (Zhu et al., 2016). Consequently, they are being actively explored as therapeutic targets, with small molecules like JH-RE-06 designed to inhibit their function and sensitize tumors to conventional therapies (Wojtaszek et al., 2019). Deficiencies in specific family members, most notably Pol eta, are the underlying cause of Xeroderma pigmentosum variant (XPV), highlighting their essential role in protecting against UV-induced genomic instability (Masutani et al., 1999). In addition to their role in eukaryotes, bacterial homologs like DinB and UmuC contribute to antibiotic resistance and stress-induced mutagenesis, making them potential targets for novel antimicrobial strategies (Naiman et al., 2014).

Other names
Translesion synthesis polymerasesTLS polymerasesDinB-like polymerasesUmuC-like polymerasesDNA polymerase etaDNA polymerase iotaDNA polymerase kappaDNA polymerase rev1
02

Mechanism of action

Inhibition of translesion synthesis (TLS) by blocking the activity or recruitment of Y-family polymerases to DNA lesion sites, thereby preventing the bypass of chemotherapy-induced DNA damage and sensitizing cancer cells to apoptosis (Wojtaszek et al., 2019).

03

Biological functions

Translesion synthesisDNA damage toleranceDNA repairSomatic hypermutationDNA replication
04

Disease associations

CancerXeroderma pigmentosum variantAntibiotic resistanceSkin cancer
05

Safety considerations

Increased genomic instabilityPotential for secondary malignanciesImpairment of normal DNA damage tolerance in healthy tissuesSynergistic toxicity with DNA-damaging agents
06

Interacting drugs

JH-RE-06

4 more in the full profile.

07

Biomarkers

POLH expressionREV1 expressionPCNA ubiquitinationRAD18 expression

Beyond the preview

Go deeper on Y-family DNA polymerase (Y-family Pols).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Y-family DNA polymerase (Y-family Pols).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call